Search
Now showing items 1-9 of 9
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial
Kapp-Schwoerer, Silke et al. (2020)
Wissenschaftlicher Artikel
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22; q22.1) acute myeloid leukemia (AML)
Agrawal, Mridul et al. (2020)
Wissenschaftlicher Artikel
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 x 2, Phase II Trial
Luebbert, Michael et al. (2020)
Wissenschaftlicher Artikel
Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin
Teich, Katrin et al. (2021)
Wissenschaftlicher Artikel
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin
Schmalbrock, Laura K. et al. (2021)
Wissenschaftlicher Artikel
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Rautenberg, Christina et al. (2021)
Wissenschaftlicher Artikel
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
Jahn, Nikolaus et al. (2020)
Wissenschaftlicher Artikel
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
Heuser, Michael et al. (2021)
Wissenschaftlicher Artikel
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
Döhner, Hartmut et al. (2022)
Wissenschaftlicher Artikel